Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125256821 | 12525682 | 1 | I | 20160511 | 20160627 | 20160705 | 20160705 | PER | US-TEVA-672693USA | TEVA | 63.86 | YR | M | Y | 98.52000 | KG | 20160705 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125256821 | 12525682 | 1 | PS | PROVIGIL | MODAFINIL | 1 | 100 MILLIGRAM DAILY; | U | UNKNOWN | 20717 | 100 | MG | TABLET | QD | |||||
| 125256821 | 12525682 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | 0 | ||||||||||||
| 125256821 | 12525682 | 3 | C | ASPIRIN. | ASPIRIN | 1 | 0 | ||||||||||||
| 125256821 | 12525682 | 4 | C | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 0 | TRANSDERMAL PATCH | ||||||||||
| 125256821 | 12525682 | 5 | C | oxycodone | OXYCODONE | 1 | 0 | ||||||||||||
| 125256821 | 12525682 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 0 | ||||||||||||
| 125256821 | 12525682 | 7 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 | ||||||||||||
| 125256821 | 12525682 | 8 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125256821 | 12525682 | 1 | Fatigue |
| 125256821 | 12525682 | 2 | Thyroid disorder |
| 125256821 | 12525682 | 3 | Prophylaxis |
| 125256821 | 12525682 | 4 | Pain |
| 125256821 | 12525682 | 5 | Pain |
| 125256821 | 12525682 | 6 | Neuralgia |
| 125256821 | 12525682 | 7 | Sleep disorder |
| 125256821 | 12525682 | 8 | Neuralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125256821 | 12525682 | Drug ineffective | |
| 125256821 | 12525682 | Erythema | |
| 125256821 | 12525682 | Intentional product misuse | |
| 125256821 | 12525682 | Product use issue | |
| 125256821 | 12525682 | Skin discolouration | |
| 125256821 | 12525682 | Somnolence | |
| 125256821 | 12525682 | Vasodilatation | |
| 125256821 | 12525682 | Vein discolouration | |
| 125256821 | 12525682 | Wrong technique in product usage process |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125256821 | 12525682 | 1 | 20160511 | 0 |